Adjuvant Nivolumab Treatment in Stage II (IIA, IIB, IIC) High-risk Melanoma
Clinical trial NCT04309409 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT04309409
- Sponsor
- University Hospital, Essen
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2020-07-01
- Primary completion
- 2027-09-01
- Enrollment
- 374
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.